Sugi Predict

Sugi Predict / Compounds / SCHEMBL23273227

SCHEMBL23273227

SCHEMBL23273227

CSCCC(NC(=O)C(N)Cc1c[nH]c2ccccc12)C(=O)NC(CC(=O)O)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(N)=O)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 10/20 0.61
▸ PTH1R Q03431 4/20 0.61
▸ GLP1R P43220 3/20 0.57
▸ CCKAR P32238 1/20 0.57
▸ IL23R Q5VWK5 1/20 0.57
▸ SLC2A1 P11166 2/20 0.57
▸ RXFP1 Q9HBX9 1/20 0.57
▸ ECE1 P42892 1/20 0.56
▸ MUS81 Q96NY9 1/20 0.56
▸ GCGR P47871 1/20 0.56
▸ GIPR P48546 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23273225 0.90 TFPI (0.54) CCKBRPTH1R
SCHEMBL29594305 0.88 GLP1R (0.68) CCKBRPTH1RGLP1RIL23RRXFP1
SCHEMBL29791120 0.88 GLP1R (0.69) CCKBRPTH1RGLP1RIL23RRXFP1
SCHEMBL29595673 0.88 GLP1R (0.64) CCKBRGLP1RCCKARIL23RECE1
SCHEMBL29963494 0.88 CCKBR (0.55) CCKBRPTH1RGLP1RCCKARIL23R
SCHEMBL30607377 0.87 IL23R (0.66) CCKBRPTH1RGLP1RIL23RECE1
SCHEMBL29594804 0.87 GLP1R (0.65) CCKBRPTH1RGLP1RIL23RRXFP1
SCHEMBL30974535 0.86 CCKBR (0.59) CCKBRCCKARIL23R
SCHEMBL20764456 0.86 TFPI (0.57) —
SCHEMBL31127542 0.86 CXCR4 (0.60) CCKBRGLP1RSLC2A1RXFP1ECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11911451-B2 Composition of tumor-associated proliferative peptides and related anti-cancer immunogen for the treatment of lung cancers and other cancers ImmuLogix Ltd (US) 2024-02-27 — — US disclosed
US-20210121546-A1 COMPOSITION OF TUMOR-ASSOCIATED PROLIFERATIVE PEPTIDES AND RELATED ANTI-CANCER IMMUNOGEN FOR THE TREATMENT OF LUNG CANCERS AND OTHER CANCERS ImmuLogix Ltd (US) 2021-04-29 — — US disclosed
Send feedback